SciSight Ecosystem
WoS SCIE Q2Scopus Q2SCImago #6,229CAS 3区Gold OA

Cardiovascular Therapeutics

Abbreviation (ISO):CARDIOVASC. THER
Country: United States•WoS SCIE Quartile: Q2•Scopus SJR: 0.857•SCImago Rank: #6,229•Identifier (ISSN):1755-5914(Print)/1755-5922(Online)•Articles / Year: 36•Estimated Publication Fee (APC): $3,191 USD
Clarivate IF (2026)Q2
2.8
↓ -0.6

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
39

39 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
36articles/year
100% Gold OA•80.88% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 2.8)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.8)
🔵 Computed
20251.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.4)
🔵 Computed
20241.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.4)
🔵 Computed
20231.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.1)
🔵 Computed
20221.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.368)
🔵 Computed
20211.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.023)
🔵 Computed
20201.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.538)
🔵 Computed
20191.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.315)
🔵 Computed
20181.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.245)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged. Subject areas include (but are by no means limited to): Acute coronary syndrome Arrhythmias Atherosclerosis Basic cardiac electrophysiology Cardiac catheterization Cardiac remodeling Coagulation and thrombosis Diabetic cardiovascular disease Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF) Hyperlipidemia Hypertension Ischemic heart disease Vascular biology Ventricular assist devices Molecular cardio-biology Myocardial regeneration Lipoprotein metabolism Radial artery access Percutaneous coronary intervention Transcatheter aortic and mitral valve replacement.

Topics Covered (Recognized by AI)
Medicine99.9%Internal medicine87%Biology77.2%Cardiology64.6%Chemistry54.9%Biochemistry52.4%Endocrinology50.8%Pathology49.8%Psychology43.9%Psychiatry41%Surgery36.6%Genetics33.9%Pharmacology30.5%Radiology27.6%Myocardial infarction25.4%Heart failure22.4%Physics22.2%

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,229Scopus Q2SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.857

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
62

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.83

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,191 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations533
3-Year Documents136
Citable Documents136

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ2
Medicine (miscellaneous)Q2
PharmacologyQ2
Pharmacology (medical)Q2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CARDIAC & CARDIOVASCULAR SYSTEMS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Quarterly
Founding Year
2008
Editorial Address
WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148
Indexing & Databases
SCIEScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
CARDIAC & CARDIOVASCULAR SYSTEMS
JCRSCIE
101/237Q2
PHARMACOLOGY & PHARMACY
JCRSCIE
181/356Q3
CARDIAC & CARDIOVASCULAR SYSTEMS
JCISCIE
76/237Q2
PHARMACOLOGY & PHARMACY
JCISCIE
120/356Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—7421
20253.466132
20243.436259
20233.134280
20223.368681,179
20213.02337640
20202.538611,169
20192.315271,120
20182.245651,105
2017—791,175
2016—851,700
2015—681,444
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Cardiovascular Therapeutics

WoS Q2
1234201820192020202120222023202420253.40
Annual Impact Factor Metric
2025:3.4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: a842072d-41b7-46a7-aa6f-b416ef9fd6cf
Database Updated: 2026-10-01